1. Home
  2. OCUL vs CLMT Comparison

OCUL vs CLMT Comparison

Compare OCUL & CLMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCUL
  • CLMT
  • Stock Information
  • Founded
  • OCUL 2006
  • CLMT 1916
  • Country
  • OCUL United States
  • CLMT United States
  • Employees
  • OCUL N/A
  • CLMT N/A
  • Industry
  • OCUL Biotechnology: Pharmaceutical Preparations
  • CLMT Oil & Gas Production
  • Sector
  • OCUL Health Care
  • CLMT Energy
  • Exchange
  • OCUL Nasdaq
  • CLMT Nasdaq
  • Market Cap
  • OCUL 1.4B
  • CLMT 1.2B
  • IPO Year
  • OCUL 2014
  • CLMT 2006
  • Fundamental
  • Price
  • OCUL $9.16
  • CLMT $20.80
  • Analyst Decision
  • OCUL Strong Buy
  • CLMT Strong Buy
  • Analyst Count
  • OCUL 8
  • CLMT 4
  • Target Price
  • OCUL $16.50
  • CLMT $24.00
  • AVG Volume (30 Days)
  • OCUL 889.3K
  • CLMT 739.7K
  • Earning Date
  • OCUL 11-14-2024
  • CLMT 11-08-2024
  • Dividend Yield
  • OCUL N/A
  • CLMT N/A
  • EPS Growth
  • OCUL N/A
  • CLMT N/A
  • EPS
  • OCUL N/A
  • CLMT N/A
  • Revenue
  • OCUL $61,442,000.00
  • CLMT $4,216,399,999.00
  • Revenue This Year
  • OCUL $15.49
  • CLMT N/A
  • Revenue Next Year
  • OCUL $13.31
  • CLMT $6.99
  • P/E Ratio
  • OCUL N/A
  • CLMT N/A
  • Revenue Growth
  • OCUL 6.45
  • CLMT 0.30
  • 52 Week Low
  • OCUL $2.05
  • CLMT $9.97
  • 52 Week High
  • OCUL $11.78
  • CLMT $25.29
  • Technical
  • Relative Strength Index (RSI)
  • OCUL 34.86
  • CLMT 51.58
  • Support Level
  • OCUL $10.46
  • CLMT $19.61
  • Resistance Level
  • OCUL $11.12
  • CLMT $22.84
  • Average True Range (ATR)
  • OCUL 0.57
  • CLMT 1.36
  • MACD
  • OCUL -0.22
  • CLMT -0.16
  • Stochastic Oscillator
  • OCUL 0.60
  • CLMT 55.58

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

About CLMT Calumet Specialty Products Partners L.P. Common Units

Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets.

Share on Social Networks: